MedPath

Add on Effect of Fesoterodine and Vibegron for Male Overactive Bladder Treated with Tadalafil Multicenter Randomized Comparative Study

Not Applicable
Conditions
overactive bladder
Registration Number
JPRN-UMIN000038483
Lead Sponsor
Department of Renal and Urologic Surgery, Asahikawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
280
Inclusion Criteria

Not provided

Exclusion Criteria

Over 100ml of postvoid residual

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath